|
Market Closed -
Hong Kong S.E.
04:08:27 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 0.4500 HKD | -5.26% |
|
+20.00% | -10.00% |
| 08-28 | Mabpharm Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-24 | Mabpharm Limited Receives Approval for New Drug Application of CMAB807X (Denosumab Injection) | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -5.26% | +20.00% | +1.12% | +7.14% | -10.00% | -28.57% | -5.26% | -51.09% | - | 237M | |
| +4.16% | -0.36% | +8.11% | +34.40% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.46B | |
| -0.61% | +0.81% | -5.03% | +6.05% | +17.41% | +27.25% | +80.21% | +220.61% | +5,462.46% | 60.14B | |
| -2.54% | -1.65% | -2.98% | -0.36% | +4.24% | +4.86% | +33.32% | -19.36% | +200.59% | 48.15B | |
| -2.81% | -4.74% | +1.41% | +28.93% | +16.22% | +28.55% | +35.12% | +8.46% | +226.66% | 44.25B | |
| +1.14% | +4.04% | -0.92% | +10.89% | +161.05% | +353.40% | +694.54% | +614.05% | - | 43.99B | |
| -1.35% | +0.21% | +0.58% | +24.07% | +18.73% | +7.63% | +102.08% | +1.12% | +1,063.61% | 41.61B | |
| +3.32% | +3.49% | -2.81% | +5.94% | +6.51% | +11.18% | +51.23% | -13.94% | +145.56% | 29.97B | |
| +4.77% | +6.16% | +14.76% | +61.99% | +78.28% | +36.77% | +22.78% | -55.69% | - | 29.31B | |
| -3.22% | -8.95% | -8.92% | +3.43% | -36.41% | -24.86% | +336.22% | +304.20% | +660.10% | 24.93B | |
| -1.12% | -2.19% | -4.76% | +3.38% | +1.99% | -5.01% | -13.89% | -61.89% | - | 24.69B | |
| -1.28% | +1.98% | +7.73% | +28.50% | +14.11% | +16.44% | -5.36% | -16.07% | +102.54% | 21.27B | |
| -3.40% | -2.71% | +3.52% | +11.07% | +7.49% | +11.00% | +148.91% | +208.62% | +1,877.55% | 17.42B | |
| -3.70% | -0.43% | -16.13% | -3.15% | +176.14% | +152.01% | +328.65% | +1,525.59% | +638.60% | 15.8B | |
| -0.61% | -4.09% | +4.16% | +8.88% | +19.46% | +18.20% | +42.41% | -29.60% | +81.10% | 14.79B | |
| -0.05% | -1.33% | -12.53% | -15.00% | - | - | - | - | - | 14.96B | |
| -5.07% | -5.42% | +24.91% | +26.27% | +31.72% | -11.60% | - | - | - | 14.78B | |
| -0.26% | +0.72% | +2.60% | +8.17% | +33.17% | +41.67% | +162.69% | +170.98% | +358.88% | 14.47B | |
| +2.96% | +0.83% | -2.05% | +11.65% | +24.17% | -5.25% | +535.77% | - | - | 14.83B | |
| -2.26% | -1.97% | +2.23% | +26.00% | +44.70% | +69.31% | +49.26% | -30.73% | +244.94% | 14.08B | |
| Average | -0.85% | +2.91% | +0.75% | +14.41% | +36.51% | +39.60% | +149.60% | +163.81% | +921.88% | 28.21B | |
| Weighted average by Cap. | -0.11% | +1.85% | +0.82% | +16.90% | +42.25% | +50.77% | +148.45% | +141.41% | +1,349.41% |
- Stock Market
- Stocks
- 2181 Stock
- Sector Mabpharm Limited
Select your edition
All financial news and data tailored to specific country editions
